359 related articles for article (PubMed ID: 18155417)
1. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?
Binard A; Le Pottier L; Saraux A; Devauchelle-Pensec V; Pers JO; Youinou P
J Autoimmun; 2008; 30(1-2):63-7. PubMed ID: 18155417
[TBL] [Abstract][Full Text] [Related]
2. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
3. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.
Mackay F; Silveira PA; Brink R
Curr Opin Immunol; 2007 Jun; 19(3):327-36. PubMed ID: 17433868
[TBL] [Abstract][Full Text] [Related]
4. Living in context with the survival factor BAFF.
Cancro MP
Immunity; 2008 Mar; 28(3):300-1. PubMed ID: 18342003
[TBL] [Abstract][Full Text] [Related]
5. Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus.
Chu VT; Enghard P; Schürer S; Steinhauser G; Rudolph B; Riemekasten G; Berek C
Arthritis Rheum; 2009 Jul; 60(7):2083-93. PubMed ID: 19565488
[TBL] [Abstract][Full Text] [Related]
6. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity.
Krumbholz M; Faber H; Steinmeyer F; Hoffmann LA; Kümpfel T; Pellkofer H; Derfuss T; Ionescu C; Starck M; Hafner C; Hohlfeld R; Meinl E
Brain; 2008 Jun; 131(Pt 6):1455-63. PubMed ID: 18474519
[TBL] [Abstract][Full Text] [Related]
7. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
Mackay F; Schneider P
Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565
[TBL] [Abstract][Full Text] [Related]
8. Unique and conserved functions of B cell-activating factor of the TNF family (BAFF) in the chicken.
Kothlow S; Morgenroth I; Graef Y; Schneider K; Riehl I; Staeheli P; Schneider P; Kaspers B
Int Immunol; 2007 Feb; 19(2):203-15. PubMed ID: 17220480
[TBL] [Abstract][Full Text] [Related]
9. An increase in B cell apoptosis by interfering BAFF-BAFF-R interaction with small synthetic molecules.
Moon EY; Yi KY; Lee S
Int Immunopharmacol; 2011 Oct; 11(10):1523-33. PubMed ID: 21620999
[TBL] [Abstract][Full Text] [Related]
10. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus.
Carter RH; Zhao H; Liu X; Pelletier M; Chatham W; Kimberly R; Zhou T
Arthritis Rheum; 2005 Dec; 52(12):3943-54. PubMed ID: 16320342
[TBL] [Abstract][Full Text] [Related]
11. Regulation of B cell self-tolerance by BAFF.
Brink R
Semin Immunol; 2006 Oct; 18(5):276-83. PubMed ID: 16916609
[TBL] [Abstract][Full Text] [Related]
12. The role of the BAFF/APRIL system on T cell function.
Mackay F; Leung H
Semin Immunol; 2006 Oct; 18(5):284-9. PubMed ID: 16931039
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy.
Yoshimoto K; Takahashi Y; Ogasawara M; Setoyama Y; Suzuki K; Tsuzaka K; Abe T; Takeuchi T
Int Immunol; 2006 Jul; 18(7):1189-96. PubMed ID: 16740602
[TBL] [Abstract][Full Text] [Related]
14. BAFF-targeting therapy, a promising strategy for treating autoimmune diseases.
Sun J; Lin Z; Feng J; Li Y; Shen B
Eur J Pharmacol; 2008 Nov; 597(1-3):1-5. PubMed ID: 18793632
[TBL] [Abstract][Full Text] [Related]
15. KR33426, [2-(2,5-dichlorophenyl)-5-methyloxazol-4yl]carbonylguanidine, is a novel compound to be effective on mouse systemic lupus erythematosus.
Lee GH; Oh JM; Kim HS; Yoon WK; Yi KY; Yang Y; Han SH; Lee S; Moon EY
Eur J Pharmacol; 2011 Oct; 668(3):459-66. PubMed ID: 21827747
[TBL] [Abstract][Full Text] [Related]
16. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.
Varin MM; Le Pottier L; Youinou P; Saulep D; Mackay F; Pers JO
Autoimmun Rev; 2010 Jul; 9(9):604-8. PubMed ID: 20457281
[TBL] [Abstract][Full Text] [Related]
17. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice.
Fletcher CA; Groom JR; Woehl B; Leung H; Mackay C; Mackay F
J Autoimmun; 2011 Mar; 36(2):125-34. PubMed ID: 21216131
[TBL] [Abstract][Full Text] [Related]
18. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.
Fletcher CA; Sutherland AP; Groom JR; Batten ML; Ng LG; Gommerman J; Mackay F
Eur J Immunol; 2006 Sep; 36(9):2504-14. PubMed ID: 16906535
[TBL] [Abstract][Full Text] [Related]
19. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of BAFF receptor, a member of the tumor necrosis factor receptor family, in malignant cells of nonhematopoietic origins.
Kohno T; Daa T; Otani H; Shimokawa I; Yokoyama S; Matsuyama T
Genes Cells; 2008 Oct; 13(10):1061-73. PubMed ID: 18775026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
